Literature DB >> 24422052

EphrinB2/EphB4 signaling can enhance and inhibit osteoclastogenesis.

.   

Abstract

Entities:  

Year:  2013        PMID： 24422052      PMCID： PMC3722733          DOI： 10.1038/bonekey.2013.29

Source DB:  PubMed          Journal:  Bonekey Rep        ISSN： 2047-6396


× No keyword cloud information.
  2 in total

1.  EphB4 enhances the process of endochondral ossification and inhibits remodeling during bone fracture repair.

Authors:  Agnieszka Arthur; Romana A Panagopoulos; Lachlan Cooper; Danijela Menicanin; Ian H Parkinson; John D Codrington; Kate Vandyke; Andrew C W Zannettino; Simon A Koblar; Natalie A Sims; Koichi Matsuo; Stan Gronthos
Journal:  J Bone Miner Res       Date:  2013-04       Impact factor: 6.741

2.  EphrinB2/EphB4 inhibition in the osteoblast lineage modifies the anabolic response to parathyroid hormone.

Authors:  Farzin M Takyar; Stephen Tonna; Patricia W M Ho; Blessing Crimeen-Irwin; Emma K Baker; T John Martin; Natalie A Sims
Journal:  J Bone Miner Res       Date:  2013-04       Impact factor: 6.741
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.